Thermo Fisher (1TMO) Ratios
Thermo Fisher Ratios
IT:1TMO's free cash flow for Q3 2026 was $2.11B. For the 2026 fiscal year, IT:1TMO's free cash flow was decreased by $-437.00M and operating cash flow was $2.55B. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.89 | 1.66 | 1.75 | 1.48 | 1.50 |
| Quick Ratio | 1.53 | 1.29 | 1.39 | 1.15 | 1.12 |
| Cash Ratio | 0.65 | 0.30 | 0.58 | 0.50 | 0.33 |
| Solvency Ratio | 0.17 | 0.20 | 0.18 | 0.19 | 0.19 |
| Operating Cash Flow Ratio | 0.51 | 0.65 | 0.60 | 0.54 | 0.71 |
| Short-Term Operating Cash Flow Coverage | 2.21 | 3.50 | 2.17 | 1.56 | 3.40 |
| Net Current Asset Value | $ -28.10B | $ -25.51B | $ -27.30B | $ -27.78B | $ -34.03B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.36 | 0.34 | 0.37 | 0.37 | 0.38 |
| Debt-to-Equity Ratio | 0.74 | 0.66 | 0.78 | 0.82 | 0.89 |
| Debt-to-Capital Ratio | 0.42 | 0.40 | 0.44 | 0.45 | 0.47 |
| Long-Term Debt-to-Capital Ratio | 0.40 | 0.37 | 0.40 | 0.40 | 0.44 |
| Financial Leverage Ratio | 2.07 | 1.96 | 2.11 | 2.21 | 2.33 |
| Debt Service Coverage Ratio | 2.20 | 2.70 | 2.03 | 1.71 | 3.25 |
| Interest Coverage Ratio | 5.71 | 4.63 | 4.99 | 11.74 | 19.25 |
| Debt to Market Cap | 0.18 | 0.16 | 0.17 | 0.16 | 0.13 |
| Interest Debt Per Share | 108.52 | 90.13 | 98.23 | 93.88 | 93.59 |
| Net Debt to EBITDA | 2.58 | 2.44 | 2.53 | 2.31 | 2.66 |
| Profitability Margins | |||||
| Gross Profit Margin | 40.93% | 41.34% | 40.12% | 42.33% | 50.07% |
| EBIT Margin | 19.49% | 20.27% | 18.17% | 19.06% | 23.91% |
| EBITDA Margin | 25.73% | 27.52% | 26.12% | 26.59% | 30.52% |
| Operating Profit Margin | 18.20% | 17.87% | 17.37% | 18.98% | 26.31% |
| Pretax Profit Margin | 16.31% | 16.31% | 14.56% | 17.06% | 22.54% |
| Net Profit Margin | 15.12% | 14.77% | 13.99% | 15.47% | 19.70% |
| Continuous Operations Profit Margin | 15.08% | 14.78% | 13.90% | 15.50% | 19.71% |
| Net Income Per EBT | 92.71% | 90.56% | 96.09% | 90.70% | 87.42% |
| EBT Per EBIT | 89.62% | 91.29% | 83.79% | 89.89% | 85.65% |
| Return on Assets (ROA) | 6.11% | 6.51% | 6.07% | 7.15% | 8.12% |
| Return on Equity (ROE) | 12.61% | 12.78% | 12.83% | 15.80% | 18.94% |
| Return on Capital Employed (ROCE) | 8.52% | 9.12% | 8.79% | 10.64% | 12.63% |
| Return on Invested Capital (ROIC) | 7.60% | 8.03% | 8.02% | 9.00% | 10.68% |
| Return on Tangible Assets | 14.92% | 17.63% | 15.76% | 18.06% | 23.37% |
| Earnings Yield | 3.09% | 3.19% | 2.93% | 3.22% | 2.94% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.22 | 4.45 | 4.43 | 4.76 | 4.38 |
| Payables Turnover | 7.27 | 8.17 | 8.94 | 7.66 | 6.83 |
| Inventory Turnover | 4.85 | 5.05 | 5.04 | 4.60 | 3.88 |
| Fixed Asset Turnover | 4.22 | 3.97 | 3.89 | 4.13 | 3.98 |
| Asset Turnover | 0.40 | 0.44 | 0.43 | 0.46 | 0.41 |
| Working Capital Turnover Ratio | 3.99 | 4.42 | 4.56 | 6.03 | 4.28 |
| Cash Conversion Cycle | 111.56 | 109.50 | 113.82 | 108.35 | 123.98 |
| Days of Sales Outstanding | 86.55 | 81.94 | 82.31 | 76.61 | 83.27 |
| Days of Inventory Outstanding | 75.24 | 72.24 | 72.37 | 79.39 | 94.17 |
| Days of Payables Outstanding | 50.23 | 44.68 | 40.85 | 47.64 | 53.45 |
| Operating Cycle | 161.79 | 154.18 | 154.67 | 155.99 | 177.44 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 20.79 | 22.69 | 21.78 | 23.35 | 24.22 |
| Free Cash Flow Per Share | 16.74 | 19.02 | 17.95 | 17.63 | 17.82 |
| Dividend Paid and CapEx Coverage Ratio | 3.62 | 4.37 | 4.20 | 3.39 | 3.27 |
| Capital Expenditure Coverage Ratio | 5.13 | 6.19 | 5.68 | 4.08 | 3.78 |
| Operating Cash Flow Coverage Ratio | 0.20 | 0.26 | 0.23 | 0.25 | 0.26 |
| Operating Cash Flow to Sales Ratio | 0.18 | 0.20 | 0.20 | 0.20 | 0.24 |
| Free Cash Flow Yield | 2.89% | 3.66% | 3.38% | 3.20% | 2.67% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 32.61 | 31.38 | 34.18 | 31.06 | 34.03 |
| Price-to-Sales (P/S) Ratio | 4.89 | 4.63 | 4.78 | 4.81 | 6.70 |
| Price-to-Book (P/B) Ratio | 4.08 | 4.01 | 4.38 | 4.91 | 6.44 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 34.62 | 27.35 | 29.58 | 31.24 | 37.45 |
| Price-to-Operating Cash Flow Ratio | 27.87 | 22.93 | 24.37 | 23.58 | 27.55 |
| Price-to-Earnings Growth (PEG) Ratio | 4.54 | 4.64 | -2.75 | -3.24 | 1.56 |
| Enterprise Value Multiple | 21.58 | 19.28 | 20.83 | 20.38 | 24.63 |
| Enterprise Value | 247.41B | 227.48B | 233.23B | 243.42B | 294.75B |
| EV to EBITDA | 21.58 | 19.28 | 20.83 | 20.38 | 24.63 |
| EV to Sales | 5.55 | 5.31 | 5.44 | 5.42 | 7.52 |
| EV to Free Cash Flow | 39.31 | 31.30 | 33.67 | 35.22 | 41.99 |
| EV to Operating Cash Flow | 31.65 | 26.25 | 27.75 | 26.59 | 30.89 |
| Tangible Book Value Per Share | -31.02 | -30.67 | -35.88 | -37.06 | -53.54 |
| Shareholders’ Equity Per Share | 142.04 | 129.80 | 121.08 | 112.19 | 103.54 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.08 | 0.09 | 0.05 | 0.09 | 0.13 |
| Revenue Per Share | 118.50 | 112.25 | 111.03 | 114.58 | 99.52 |
| Net Income Per Share | 17.92 | 16.58 | 15.53 | 17.73 | 19.61 |
| Tax Burden | 0.93 | 0.91 | 0.96 | 0.91 | 0.87 |
| Interest Burden | 0.84 | 0.80 | 0.80 | 0.90 | 0.94 |
| Research & Development to Revenue | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 |
| SG&A to Revenue | 0.20 | 0.20 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Income Quality | 1.16 | 1.37 | 1.40 | 1.32 | 1.23 |
Currency in USD
